QUZYTTIR Trademark

Trademark Overview

On Friday, October 12, 2018, a trademark application was filed for QUZYTTIR with the United States Patent and Trademark Office. The USPTO has given the QUZYTTIR trademark a serial number of 88153622. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, November 4, 2025. This trademark is owned by JDP THERAPEUTICS INC.. The QUZYTTIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, injections for the treatment of acute urticaria, angioedema and acute allergic reactions
quzyttir

General Information

Serial Number88153622
Word MarkQUZYTTIR
Filing DateFriday, October 12, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, November 4, 2025
Registration Number6034685
Registration DateTuesday, April 14, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

Goods and ServicesPharmaceutical products, namely, injections for the treatment of acute urticaria, angioedema and acute allergic reactions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 24, 2018
Primary Code005
First Use Anywhere DateWednesday, October 9, 2019
First Use In Commerce DateThursday, February 13, 2020

Trademark Owner History

Party NameJDP THERAPEUTICS LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015
Party NameJDP THERAPEUTICS LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressDOVER, DE 19904
Party NameJDP THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLandsdale, PA 19446
Party NameJDP THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLandsdale, PA 19446

Trademark Events

Event DateEvent Description
Tuesday, October 16, 2018NEW APPLICATION ENTERED
Wednesday, October 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 23, 2019ASSIGNED TO EXAMINER
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 24, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019SOU EXTENSION 1 FILED
Tuesday, October 1, 2019SOU EXTENSION 1 GRANTED
Thursday, October 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 14, 2020TEAS STATEMENT OF USE RECEIVED
Friday, March 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 14, 2020USE AMENDMENT FILED
Friday, March 6, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 9, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 10, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 15, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, April 14, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 10, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, November 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 4, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 4, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

quzyttir acute urticaria angioedema allergic reactions treatment products namely injections pharmaceutical